RESUMO
CONTEXT: In France, 2300 adolescents and young adults (AYAs, 15-25 years old) are diagnosed with cancer each year. As soon as the disease is diagnosed, a number of physical, psychological and social needs may arise. The aim of this study is to develop a tool to measure unmet needs that will allow the specificities of AYAs to be understood while allowing health care staff to mobilise the necessary actors to resolve them. METHODS: We developed the Questionnaire nEEd Cancer AYAs (QUEEC-AYAs questionnaire), from two existing questionnaires: the Cancer Needs Questionnaire Young People and the Needs Assessment & Service Bridge. A main sample of 103 AYAs then received and completed the questionnaire in order to conduct an exploratory factor analysis. RESULTS: The final structure of the QUEEC-AYAs is composed of 7 dimensions and 48 items: information (8 items), cancer care team (6 items), Physical health (4 items), Emotional health (14 items), Sexual & reproductive health (6 items), Health behaviors & wellness (4 items), Daily life (6 items). The questionnaire has a good acceptability and all domains have a Cronbach's alphas value above 0.80. CONCLUSION: The QUEEC-AYAs is the first measure of the psychosocial needs of AYAs available in French. Its systematic use in health care services should improve the coordination of care required by AYAs during and after treatment. TRIAL REGISTRATION: This study was approved by the ethics committee of the Paoli-Calmettes Institute (IRB # IPC 2021-041, 2021 May 20).
Assuntos
Avaliação das Necessidades , Neoplasias , Humanos , Inquéritos e Questionários , Adolescente , Neoplasias/psicologia , Neoplasias/terapia , Adulto Jovem , Feminino , Masculino , França , Adulto , Psicometria , Reprodutibilidade dos Testes , Necessidades e Demandas de Serviços de Saúde , Qualidade de Vida/psicologiaRESUMO
Microcapsules containing citronella essential oil were prepared by complex coacervation and applied to cotton textiles in order to study the repellent efficacy of the obtained fabrics. Citronella released from treated textiles was indirectly monitored by the extractable content of its main components. Repellent activity was assessed by exposure of a human hand and arm covered with the treated textiles to Aedes aegypti mosquitoes. Fabrics treated with microencapsulated citronella presented a higher and longer lasting protection from insects compared to fabrics sprayed with an ethanol solution of the essential oil, assuring a repellent effect higher than 90% for three weeks. Complex coacervation is a simple, low cost, scalable and reproducible method of obtaining encapsulated essential oils for textile application. Repellent textiles were achieved by padding cotton fabrics with microcapsules slurries using a conventional pad-dry method. This methodology requires no additional investment for textile finishing industries, which is a desirable factor in developing countries.
Assuntos
Culicidae , Repelentes de Insetos , Malária/prevenção & controle , Extratos Vegetais , Óleos de Plantas , Têxteis , Animais , Análise Custo-Benefício , Composição de Medicamentos , Humanos , Repelentes de Insetos/economia , Óleos de Plantas/economiaRESUMO
BACKGROUND: Using data from the PACS 01 randomized trial, we evaluated the cost-effectiveness of anthracyclines plus docetaxel (Taxotere; FEC-D) versus anthracyclines alone (FEC100) in patients with node-positive breast cancer. PATIENTS AND METHODS: Costs and outcomes were assessed in 1996 patients and the incremental cost-effectiveness ratios (ICERs) were estimated, using quality-adjusted life years (QALYs) as outcome. To deal with uncertainty due to sampling fluctuations, confidence regions around the ICERs were calculated and cost-effectiveness acceptability curves were drawn up. Sensitivity analyses were also carried out to assess the robustness of conclusions. RESULTS: The mean cost of treatment was 33% higher with strategy FEC-D, but this difference decreased to 18% at a 5-year horizon. The ICER of FEC-D versus FEC100 was estimated to be 9665euro per QALY gained (95% confidence interval euro2372-euro55 515). The estimated probability that FEC-D was cost-effective reached >96% for a threshold of euro50 000 per QALY gained. If the price of taxane decreased slightly, the ICER would reach some very reasonable levels and this strategy would therefore be much more cost-effective. CONCLUSION: The sequential use of FEC100 followed by docetaxel appears to be a cost-effective alternative, even when uncertainty is taken into account.
Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Neoplasias da Mama/economia , Linfonodos/patologia , Adulto , Idoso , Antraciclinas/administração & dosagem , Neoplasias da Mama/patologia , Quimioterapia Adjuvante , Análise Custo-Benefício , Docetaxel , Feminino , Humanos , Pessoa de Meia-Idade , Modelos Econômicos , Metástase Neoplásica , Estadiamento de Neoplasias , Anos de Vida Ajustados por Qualidade de Vida , Taxa de Sobrevida , Taxoides/administração & dosagem , Resultado do TratamentoAssuntos
Antineoplásicos/economia , Neoplasias da Mama/tratamento farmacológico , Antineoplásicos/efeitos adversos , Neoplasias da Mama/mortalidade , Terapias Complementares/economia , Efeitos Psicossociais da Doença , Análise Custo-Benefício , Docetaxel , Custos de Medicamentos , Humanos , Neutropenia/induzido quimicamente , Neutropenia/economia , Paclitaxel/uso terapêutico , Qualidade de Vida , Anos de Vida Ajustados por Qualidade de Vida , Análise de Sobrevida , Taxoides/uso terapêutico , Terapias em Estudo/economiaRESUMO
The involvement of inflammatory cells in the pathogenesis of chronic obstructive pulmonary disease (COPD) and asthma is well established. This study aimed to quantify differences in inflammatory cell function in situ in these patients as compared to normal subjects. Positron emission tomography was used to assess neutrophil activity (18F-fluorodeoxyglucose (18FDG)) and macrophage accumulation (11C-PK11195) in six patients with COPD, six chronic asthmatics and five age-matched normal control subjects. 18FDG uptake was greater in COPD than in normal subjects, with no increase in asthmatics. The mean slope of 18FDG uptake, corrected for volume of distribution, was 4.0 min(-1) in COPD patients compared with 1.5 min(-1) in control subjects and 1.7 min(-1) in asthmatics. Mean 11C-PK11195 uptake (plateau tissue:plasma) was higher in four of six COPD patients (10.8) and three of five asthmatics (11.8) than the maximum value in control subjects (6.2). From this preliminary study the authors conclude that positron emission tomography may be useful to assess polymorphonuclear neutrophil and macrophage activity in vivo in chronic obstructive pulmonary disease and asthma, and may reveal differences in cell behaviour between the study groups. In addition, positron emission tomography may provide indices of disease activity for future therapeutic studies.
Assuntos
Asma/diagnóstico por imagem , Asma/imunologia , Doença Pulmonar Obstrutiva Crônica/diagnóstico por imagem , Doença Pulmonar Obstrutiva Crônica/imunologia , Tomografia Computadorizada de Emissão , Idoso , Análise de Variância , Estudos de Casos e Controles , Contagem de Células , Feminino , Fluordesoxiglucose F18 , Humanos , Isoquinolinas , Macrófagos/imunologia , Masculino , Pessoa de Meia-Idade , Neutrófilos/imunologia , Projetos Piloto , Compostos Radiofarmacêuticos , Escarro/citologiaAssuntos
Marketing de Serviços de Saúde/organização & administração , Administração de Linha de Produção/organização & administração , Pessoal Administrativo , Tomada de Decisões Gerenciais , Grupos Diagnósticos Relacionados , Competição Econômica , Humanos , Estudos de Casos Organizacionais , Papel do Médico , Administração de Linha de Produção/classificação , Estados UnidosRESUMO
This paper describes the Cleveland Clinic Foundation's experience with the development and implementation of a 20-page quality indicator consumer guide for patients with or at risk of developing coronary artery disease. The guide, which provides six "quality indicators," was designed to enable patients to evaluate and compare quality-related information when choosing a provider. Design elements for the guide included a user-friendly format to offset the amount of information consumers are asked to absorb. Data on inquiries showed that the majority were women (53%) and adults under the age of 65 years (57%). Although the media criticized the guide as a marketing tool, it represents an effort to educate consumers about the importance of research when choosing a provider.